NCT01355380View on ClinicalTrials.gov

Efficacy of Ventavis Used in Real-life Setting.

CompletedOBSERVATIONAL

Enrollment

55

Participants

Timeline

Start Date

August 5, 2010

Primary Completion Date

April 28, 2016

Study Completion Date

September 22, 2016

Conditions

Pulmonary Arterial Hypertension

Interventions

DRUG

Inhaled iloprost (Ventavis, BAYQ6256)

Patients treated with inhaled iloprost (Ventavis) 2.5 or 5 micrograms 6-9 times daily

Trial Locations (1)

Unknown

Many Locations

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Bayer

INDUSTRY